The US Supreme Court declined to hear former pharmaceutical company CEO Martin Shkreli's challenge to a $64.6 million financial penalty imposed by a judge after he raised a lifesaving drug's price by more than 4,000% https://t.co/IrCDUhDSlB
๐ from @AARPMedia: AARP reacts to first Medicare-negotiated Rx prices.
๐ โTodayโs announcement marks a significant step forward in our long-standing efforts to lower prescription drug prices.โ - @NancyLeaMond
๐ฐ Read more: https://t.co/bALYQ4Z3lC
#AARPNY delivered 4,000+ letters to @CarlHeastieโs #Bronx office today urging him to put prescription drug importation bill to a vote in #NYSAssembly to OK safe import of #Rx to NYS. Time is running out on 2024 session. NY needs action now! #FairRxPricesNow
@hborrud If they are, they should be documenting everything exceedingly well so that it can be shown that the funds went to an activity legal for a c3.